Subclinical abnormal glucose tolerance is a predictor of death in liver cirrhosis
Authors:
- Diego García-CompeánDGDiego García-Compeán
- Joel Omar Jáquez-QuintanaJJJoel Omar Jáquez-Quintana
- Fernando Javier Lavalle-GonzálezFLFernando Javier Lavalle-González
- José Alberto González-GonzálezJGJosé Alberto González-González
- Linda Elsa Muñoz-EspinosaLMLinda Elsa Muñoz-Espinosa
- Jesús Zacarías Villarreal-PérezJVJesús Zacarías Villarreal-Pérez
- Héctor J Maldonado-GarzaHMHéctor J Maldonado-Garza
Open Access
- 1 January 2014
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (22) , 7011-8
Abstract
To determine if subclinical abnormal glucose tolerance (SAGT) has influence on survival of non-diabetic patients with liver cirrhosis. In total, 100 patients with compensated liver cirrhosis and normal fasting plasma glucose were included. Fasting plasma insulin (FPI) levels were measured, and oral glucose tolerance test (OGTT) was performed. According to OGTT results two groups of patients were formed: those with normal glucose tolerance (NGT) and those with SAGT. Patients were followed every three months. The mean follow-up was 932 d (range of 180-1925). Survival was analyzed by the Kaplan-Meyer method, and predictive factors of death were analyzed using the Cox proportional hazard regression model. Of the included patients, 30 showed NGT and 70 SAGT. Groups were significantly different only in age, INR, FPI and HOMA2-IR. Patients with SAGT showed lower 5-year cumulated survival than NGT patients (31.7% vs 71.6%, P = 0.02). Differences in survival were significant only after 3 years of follow-up. SAGT, Child-Pugh B, and high Child-Pugh and Model for End-Stage Liver Disease (MELD) scores were independent predictors of death. The causes of death in 90.3% of cases were due to complications related to liver disease. SAGT was associated with lower survival. SAGT, Child-Pugh B, and high Child-Pugh and MELD scores were independent negative predictors of survival.Keywords
This publication has 46 references indexed in Scilit:
- Liver and diabetes. A vicious circleHepatology Research, 2012
- Hepatogenous diabetes. Current views of an ancient problemAnnals of Hepatology, 2009
- The model for end-stage liver disease (MELD)Hepatology, 2007
- Association Between Liver Fibrosis and Insulin Sensitivity in Chronic Hepatitis C PatientsAmerican Journal of Gastroenterology, 2006
- Oral Glucose Tolerance Test Predicts Prognosis of Patients with Liver CirrhosisAmerican Journal of Gastroenterology, 2006
- Adiponectin – a key adipokine in the metabolic syndromeDiabetes, Obesity and Metabolism, 2005
- Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO ConsultationDiabetic Medicine, 1998
- Insulin resistance in cirrhosis: Prolonged reduction of hyperinsulinemia normalizes insulin sensitivityHepatology, 1998
- Prognostic significance of diabetes in patients with cirrhosis*1Hepatology, 1994
- Abnormalities of glucose metabolism induced by liver cirrhosis and glycosylated hemoglobin levels in chronic liver disease.1988